117 related articles for article (PubMed ID: 22885104)
1. Targeting host syntaxin-5 preferentially blocks Leishmania parasitophorous vacuole development in infected cells and limits experimental Leishmania infections.
Canton J; Kima PE
Am J Pathol; 2012 Oct; 181(4):1348-55. PubMed ID: 22885104
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the fusion of Leishmania parasitophorous vacuoles with ER vesicles results in the control of the infection.
Canton J; Ndjamen B; Hatsuzawa K; Kima PE
Cell Microbiol; 2012 Jun; 14(6):937-48. PubMed ID: 22309219
[TBL] [Abstract][Full Text] [Related]
3. Structurally optimized analogs of the retrograde trafficking inhibitor Retro-2cycl limit Leishmania infections.
Craig E; Huyghues-Despointes CE; Yu C; Handy EL; Sello JK; Kima PE
PLoS Negl Trop Dis; 2017 May; 11(5):e0005556. PubMed ID: 28505157
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
[TBL] [Abstract][Full Text] [Related]
5. The host cell secretory pathway mediates the export of Leishmania virulence factors out of the parasitophorous vacuole.
Arango Duque G; Jardim A; Gagnon É; Fukuda M; Descoteaux A
PLoS Pathog; 2019 Jul; 15(7):e1007982. PubMed ID: 31356625
[TBL] [Abstract][Full Text] [Related]
6. Control of parasitophorous vacuole expansion by LYST/Beige restricts the intracellular growth of Leishmania amazonensis.
Wilson J; Huynh C; Kennedy KA; Ward DM; Kaplan J; Aderem A; Andrews NW
PLoS Pathog; 2008 Oct; 4(10):e1000179. PubMed ID: 18927622
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
Vendrametto MC; Santos AO; Nakamura CV; Dias Filho BP; Cortez DA; Ueda-Nakamura T
Parasitol Int; 2010 Jun; 59(2):154-8. PubMed ID: 20064628
[TBL] [Abstract][Full Text] [Related]
8. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes.
Arrais-Silva WW; Collhone MC; Ayres DC; de Souza Souto PC; Giorgio S
Parasitol Int; 2005 Mar; 54(1):1-7. PubMed ID: 15710544
[TBL] [Abstract][Full Text] [Related]
9. [Role of the parasitophorous vacuole of murine macrophages infected with Leishmania amazonensis in molecule acquisition].
Cortázar TM; Hernández J; Echeverry MC; Camacho M
Biomedica; 2006 Oct; 26 Suppl 1():26-37. PubMed ID: 17361839
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis.
Honda PA; Ferreira IC; Cortez DA; Amado CA; Silveira TG; Brenzan MA; Lonardoni MV
Phytomedicine; 2010 Apr; 17(5):333-8. PubMed ID: 19800777
[TBL] [Abstract][Full Text] [Related]
11. Redistribution of plasma-membrane surface molecules during formation of the Leishmania amazonensis-containing parasitophorous vacuole.
Henriques C; de Souza W
Parasitol Res; 2000 Mar; 86(3):215-25. PubMed ID: 10726992
[TBL] [Abstract][Full Text] [Related]
12. In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham.
de Medeiros Md; da Silva AC; Citó AM; Borges AR; de Lima SG; Lopes JA; Figueiredo RC
Parasitol Int; 2011 Sep; 60(3):237-41. PubMed ID: 21421075
[TBL] [Abstract][Full Text] [Related]
13. The ultrastructure of the parasitophorous vacuole formed by Leishmania major.
Castro R; Scott K; Jordan T; Evans B; Craig J; Peters EL; Swier K
J Parasitol; 2006 Dec; 92(6):1162-70. PubMed ID: 17304790
[TBL] [Abstract][Full Text] [Related]
14. Central nervous system involvement in experimental infection with Leishmania (Leishmania) amazonensis.
Abreu-Silva AL; Calabrese KS; Tedesco RC; Mortara RA; Gonçalves da Costa SC
Am J Trop Med Hyg; 2003 Jun; 68(6):661-5. PubMed ID: 12887024
[TBL] [Abstract][Full Text] [Related]
15. Leishmania (L.) amazonensis: fusion between parasitophorous vacuoles in infected bone-marrow derived mouse macrophages.
Real F; Pouchelet M; Rabinovitch M
Exp Parasitol; 2008 May; 119(1):15-23. PubMed ID: 18346736
[TBL] [Abstract][Full Text] [Related]
16. Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro.
Vendrame CM; Carvalho MD; Rios FJ; Manuli ER; Petitto-Assis F; Goto H
Scand J Immunol; 2007; 66(2-3):287-96. PubMed ID: 17635806
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescent Leishmania expressing luciferase for rapid and high throughput screening of drugs acting on amastigote-harbouring macrophages and for quantitative real-time monitoring of parasitism features in living mice.
Lang T; Goyard S; Lebastard M; Milon G
Cell Microbiol; 2005 Mar; 7(3):383-92. PubMed ID: 15679841
[TBL] [Abstract][Full Text] [Related]
18. A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate.
Barroso PA; Marco JD; Calvopina M; Kato H; Korenaga M; Hashiguchi Y
J Antimicrob Chemother; 2007 Jun; 59(6):1123-9. PubMed ID: 17439977
[TBL] [Abstract][Full Text] [Related]
19. CrATP interferes in the promastigote-macrophage interaction in Leishmania amazonensis infection.
Ennes-Vidal V; Castro RO; Britto C; Barrabin H; D'Avila-Levy CM; Moreira OC
Parasitology; 2011 Jul; 138(8):960-8. PubMed ID: 21679488
[TBL] [Abstract][Full Text] [Related]
20. Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI.
Arango Duque G; Fukuda M; Turco SJ; Stäger S; Descoteaux A
J Immunol; 2014 Sep; 193(5):2363-72. PubMed ID: 25063865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
